ID   KAPCA_BOVIN             Reviewed;         351 AA.
AC   P00517;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-JUL-2015, entry version 161.
DE   RecName: Full=cAMP-dependent protein kinase catalytic subunit alpha;
DE            Short=PKA C-alpha;
DE            EC=2.7.11.11;
GN   Name=PRKACA;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   PubMed=1420367; DOI=10.1016/0167-4781(92)90144-O;
RA   Wiemann S., Kinzel V., Pyerin W.;
RT   "Cloning of the C alpha catalytic subunit of the bovine cAMP-dependent
RT   protein kinase.";
RL   Biochim. Biophys. Acta 1171:93-96(1992).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-351, MYRISTOYLATION AT GLY-2, AND
RP   PHOSPHORYLATION AT THR-198 AND SER-339.
RX   PubMed=6262777; DOI=10.1073/pnas.78.2.848;
RA   Shoji S., Parmelee D.C., Wade R.D., Kumar S., Ericsson L.H.,
RA   Walsh K.A., Neurath H., Lonh G.L., Demaille J.G., Fischer E.H.,
RA   Titani K.;
RT   "Complete amino acid sequence of the catalytic subunit of bovine
RT   cardiac muscle cyclic AMP-dependent protein kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:848-851(1981).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-351.
RX   PubMed=6311252; DOI=10.1021/bi00284a025;
RA   Shoji S., Ericsson L.H., Walsh K.A., Fischer E.H., Titani K.;
RT   "Amino acid sequence of the catalytic subunit of bovine type II
RT   adenosine cyclic 3',5'-phosphate dependent protein kinase.";
RL   Biochemistry 22:3702-3709(1983).
RN   [4]
RP   PROTEIN SEQUENCE OF 196-214, AND ACTIVE SITE.
RX   PubMed=6286662;
RA   Bramson H.N., Thomas N., Matsueda R., Nelson N.C., Taylor S.S.,
RA   Kaiser E.T.;
RT   "Modification of the catalytic subunit of bovine heart cAMP-dependent
RT   protein kinase with affinity labels related to peptide substrates.";
RL   J. Biol. Chem. 257:10575-10581(1982).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-8, MUTAGENESIS OF ASN-3, AND DEAMIDATION AT
RP   ASN-3.
RX   PubMed=9521123; DOI=10.1002/pro.5560070227;
RA   Jedrzejewski P.T., Girod A., Tholey A., Koenig N., Thullner S.,
RA   Kinzel V., Bossemeyer D.;
RT   "A conserved deamidation site at Asn 2 in the catalytic subunit of
RT   mammalian cAMP-dependent protein kinase detected by capillary LC-MS
RT   and tandem mass spectrometry.";
RL   Protein Sci. 7:457-469(1998).
RN   [6]
RP   DEAMIDATION AT ASN-3, AND SUBCELLULAR LOCATION.
RX   PubMed=10684253; DOI=10.1083/jcb.148.4.715;
RA   Pepperkok R., Hotz-Wagenblatt A., Koenig N., Girod A., Bossemeyer D.,
RA   Kinzel V.;
RT   "Intracellular distribution of mammalian protein kinase A catalytic
RT   subunit altered by conserved Asn2 deamidation.";
RL   J. Cell Biol. 148:715-726(2000).
RN   [7]
RP   DEAMIDATION AT ASN-3, AND CHARACTERIZATION OF ASP-3 ISOMERS.
RX   PubMed=11152138; DOI=10.1110/ps.9.11.2269;
RA   Kinzel V., Koenig N., Pipkorn R., Bossemeyer D., Lehmann W.D.;
RT   "The amino terminus of PKA catalytic subunit- a site for introduction
RT   of posttranslational heterogeneities by deamidation: D-Asp2 and D-
RT   isoAsp2 containing isozymes.";
RL   Protein Sci. 9:2269-2277(2000).
RN   [8]
RP   INTERACTION WITH RAB13.
RX   PubMed=15096524; DOI=10.1083/jcb.200312118;
RA   Koehler K., Louvard D., Zahraoui A.;
RT   "Rab13 regulates PKA signaling during tight junction assembly.";
RL   J. Cell Biol. 165:175-180(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
RX   PubMed=8824261; DOI=10.1074/jbc.271.42.26157;
RA   Engh R.A., Girod A., Kinzel V., Huber R., Bossemeyer D.;
RT   "Crystal structures of catalytic subunit of cAMP-dependent protein
RT   kinase in complex with isoquinolinesulfonyl protein kinase inhibitors
RT   H7, H8, and H89. Structural implications for selectivity.";
RL   J. Biol. Chem. 271:26157-26164(1996).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=9438863; DOI=10.1016/S0969-2126(97)00310-9;
RA   Prade L., Engh R.A., Girod A., Kinzel V., Huber R., Bossemeyer D.;
RT   "Staurosporine-induced conformational changes of cAMP-dependent
RT   protein kinase catalytic subunit explain inhibitory potential.";
RL   Structure 5:1627-1637(1997).
CC   -!- FUNCTION: Phosphorylates a large number of substrates in the
CC       cytoplasm and the nucleus. Regulates the abundance of
CC       compartmentalized pools of its regulatory subunits through
CC       phosphorylation of PJA2 which binds and ubiquitinates these
CC       subunits, leading to their subsequent proteolysis. Phosphorylates
CC       CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA and VASP.
CC       RORA is activated by phosphorylation. Required for glucose-
CC       mediated adipogenic differentiation increase and osteogenic
CC       differentiation inhibition from osteoblasts. Involved in the
CC       regulation of platelets in response to thrombin and collagen;
CC       maintains circulating platelets in a resting state by
CC       phosphorylating proteins in numerous platelet inhibitory pathways
CC       when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-
CC       alpha (NFKBIA), but thrombin and collagen disrupt these complexes
CC       and free active PRKACA stimulates platelets and leads to platelet
CC       aggregation by phosphorylating VASP. Prevents the
CC       antiproliferative and anti-invasive effects of alpha-
CC       difluoromethylornithine in breast cancer cells when activated.
CC       RYR2 channel activity is potentiated by phosphorylation in
CC       presence of luminal Ca(2+), leading to reduced amplitude and
CC       increased frequency of store overload-induced Ca(2+) release
CC       (SOICR) characterized by an increased rate of Ca(2+) release and
CC       propagation velocity of spontaneous Ca(2+) waves, despite reduced
CC       wave amplitude and resting cytosolic Ca(2+). PSMC5/RPT6 activation
CC       by phosphorylation stimulates proteasome. Negatively regulates
CC       tight junctions (TJs) in ovarian cancer cells via CLDN3
CC       phosphorylation. NFKB1 phosphorylation promotes NF-kappa-B p50-p50
CC       DNA binding. Involved in embryonic development by down-regulating
CC       the Hedgehog (Hh) signaling pathway that determines embryo pattern
CC       formation and morphogenesis. Prevents meiosis resumption in
CC       prophase-arrested oocytes via CDC25B inactivation by
CC       phosphorylation. May also regulate rapid eye movement (REM) sleep
CC       in the pedunculopontine tegmental (PPT) (By similarity).
CC       Phosphorylates APOBEC3G and AICDA (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Allosterically activated by various compounds,
CC       including ATP. Activated by cAMP; the nucleotide acts as a dynamic
CC       and allosteric activator by coupling the two lobes of apo PKA,
CC       enhancing the enzyme dynamics synchronously and priming it for
CC       catalysis.
CC   -!- SUBUNIT: A number of inactive tetrameric holoenzymes are produced
CC       by the combination of homo- or heterodimers of the different
CC       regulatory subunits associated with two catalytic subunits. cAMP
CC       causes the dissociation of the inactive holoenzyme into a dimer of
CC       regulatory subunits bound to four cAMP and two free monomeric
CC       catalytic subunits. Activates cAMP-sensitive PKAI and PKAII
CC       holoenzymes by interacting with regulatory subunit (R) of PKA,
CC       PRKAR1A/PKR1 and PRKAR2A/PKR2, respectively. Interacts with NFKB1,
CC       NFKB2 and NFKBIA in platelets; these interactions are disrupted by
CC       thrombin and collagen. Binds to ABL1 in spermatozoa and with
CC       CDC25B in oocytes (By similarity). Interacts with APOBEC3G and
CC       AICDA (By similarity). Interacts with RAB13; downstream effector
CC       of RAB13 involved in tight junction assembly. {ECO:0000250,
CC       ECO:0000269|PubMed:15096524}.
CC   -!- INTERACTION:
CC       P63251:Kcnj3 (xeno); NbExp=6; IntAct=EBI-7251007, EBI-7250981;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10684253}.
CC       Nucleus {ECO:0000269|PubMed:10684253}. Cell membrane
CC       {ECO:0000250}. Mitochondrion {ECO:0000250}. Note=Translocates into
CC       the nucleus (monomeric catalytic subunit). The inactive holoenzyme
CC       is found in the cytoplasm. Distributed throughout the cytoplasm in
CC       meiotically incompetent oocytes. Associated to mitochondrion as
CC       meiotic competence is acquired. Aggregates around the germinal
CC       vesicles (GV) at the immature GV stage oocytes (By similarity).
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in mammalian tissues.
CC   -!- PTM: Asn-3 is deaminated to Asp in more than 25% of the proteins,
CC       giving rise to 2 major isoelectric variants, called CB and CA
CC       respectively (0.4 pH unit change). Deamidation proceeds via the
CC       so-called beta-aspartyl shift mechanism and yields either 'D-Asp-
CC       3' (major) or 'D-isoAsp-2' (minor), in addition to L-isomers.
CC       Deamidation occurs after the addition of myristate. The Asn-3 form
CC       reaches a significantly larger nuclear/cytoplasmic ratio than the
CC       'Asp-2' form. {ECO:0000269|PubMed:10684253,
CC       ECO:0000269|PubMed:11152138, ECO:0000269|PubMed:6262777,
CC       ECO:0000269|PubMed:9521123}.
CC   -!- PTM: Autophosphorylated. Phosphorylation is enhanced by vitamin
CC       K(2). Phosphorylated on threonine and serine residues.
CC       Phosphorylation on Thr-198 is required for full activity (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated at Tyr-331 by activated receptor tyrosine
CC       kinases EGFR and PDGFR; this increases catalytic efficienncy.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cAMP subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X67154; CAA47627.1; -; mRNA.
DR   PIR; S27159; OKBO2C.
DR   RefSeq; NP_777009.1; NM_174584.2.
DR   UniGene; Bt.4420; -.
DR   PDB; 1KMU; Model; -; C=9-351.
DR   PDB; 1KMW; Model; -; C=9-351.
DR   PDB; 1Q24; X-ray; 2.60 A; A=2-351.
DR   PDB; 1Q61; X-ray; 2.10 A; A=2-351.
DR   PDB; 1Q62; X-ray; 2.30 A; A=2-351.
DR   PDB; 1Q8T; X-ray; 2.00 A; A=2-351.
DR   PDB; 1Q8U; X-ray; 1.90 A; A=2-351.
DR   PDB; 1Q8W; X-ray; 2.20 A; A=2-351.
DR   PDB; 1SMH; X-ray; 2.04 A; A=2-351.
DR   PDB; 1STC; X-ray; 2.30 A; E=2-351.
DR   PDB; 1SVE; X-ray; 2.49 A; A=2-351.
DR   PDB; 1SVG; X-ray; 2.02 A; A=2-351.
DR   PDB; 1SVH; X-ray; 2.30 A; A=2-351.
DR   PDB; 1SZM; X-ray; 2.50 A; A/B=2-351.
DR   PDB; 1VEB; X-ray; 2.89 A; A=2-351.
DR   PDB; 1XH4; X-ray; 2.45 A; A=2-351.
DR   PDB; 1XH5; X-ray; 2.05 A; A=2-351.
DR   PDB; 1XH6; X-ray; 1.90 A; A=2-351.
DR   PDB; 1XH7; X-ray; 2.47 A; A=2-351.
DR   PDB; 1XH8; X-ray; 1.60 A; A=2-351.
DR   PDB; 1XH9; X-ray; 1.64 A; A=2-351.
DR   PDB; 1XHA; X-ray; 2.46 A; A=2-351.
DR   PDB; 1YDR; X-ray; 2.20 A; E=2-351.
DR   PDB; 1YDS; X-ray; 2.20 A; E=2-351.
DR   PDB; 1YDT; X-ray; 2.30 A; E=2-351.
DR   PDB; 2C1A; X-ray; 1.95 A; A=2-351.
DR   PDB; 2C1B; X-ray; 2.00 A; A=2-351.
DR   PDB; 2F7E; X-ray; 2.00 A; E=1-351.
DR   PDB; 2F7X; X-ray; 1.90 A; E=1-351.
DR   PDB; 2F7Z; X-ray; 3.00 A; E=1-351.
DR   PDB; 2GFC; X-ray; 1.87 A; A=2-351.
DR   PDB; 2GNF; X-ray; 2.28 A; A=2-351.
DR   PDB; 2GNG; X-ray; 1.87 A; A=2-351.
DR   PDB; 2GNH; X-ray; 2.05 A; A=2-351.
DR   PDB; 2GNI; X-ray; 2.27 A; A=2-351.
DR   PDB; 2GNJ; X-ray; 2.28 A; A=2-351.
DR   PDB; 2GNL; X-ray; 2.60 A; A=2-351.
DR   PDB; 2JDS; X-ray; 2.00 A; A=2-351.
DR   PDB; 2JDT; X-ray; 2.15 A; A=2-351.
DR   PDB; 2JDV; X-ray; 2.08 A; A=2-351.
DR   PDB; 2OH0; X-ray; 2.20 A; E=1-351.
DR   PDB; 2OJF; X-ray; 2.10 A; E=1-351.
DR   PDB; 2UVX; X-ray; 2.00 A; A=2-351.
DR   PDB; 2UVY; X-ray; 1.95 A; A=2-351.
DR   PDB; 2UVZ; X-ray; 1.94 A; A=2-351.
DR   PDB; 2UW0; X-ray; 2.00 A; A=2-351.
DR   PDB; 2UW3; X-ray; 2.19 A; A=2-351.
DR   PDB; 2UW4; X-ray; 2.00 A; A=2-351.
DR   PDB; 2UW5; X-ray; 2.14 A; A=2-351.
DR   PDB; 2UW6; X-ray; 2.23 A; A=2-351.
DR   PDB; 2UW7; X-ray; 2.10 A; A=2-351.
DR   PDB; 2UW8; X-ray; 2.00 A; A=2-351.
DR   PDB; 2UZT; X-ray; 2.10 A; A=16-351.
DR   PDB; 2UZU; X-ray; 2.40 A; E=16-351.
DR   PDB; 2UZV; X-ray; 2.50 A; A=16-351.
DR   PDB; 2UZW; X-ray; 2.20 A; E=16-351.
DR   PDB; 2VNW; X-ray; 2.09 A; A=1-351.
DR   PDB; 2VNY; X-ray; 1.96 A; A=1-351.
DR   PDB; 2VO0; X-ray; 1.94 A; A=1-351.
DR   PDB; 2VO3; X-ray; 1.98 A; A=1-351.
DR   PDB; 2VO6; X-ray; 1.97 A; A=1-351.
DR   PDB; 2VO7; X-ray; 1.98 A; A=1-351.
DR   PDB; 3AG9; X-ray; 2.00 A; A/B=1-351.
DR   PDB; 3BWJ; X-ray; 2.30 A; A=2-351.
DR   PDB; 3DND; X-ray; 2.26 A; A=2-351.
DR   PDB; 3DNE; X-ray; 2.00 A; A=2-351.
DR   PDB; 3E8C; X-ray; 2.20 A; A/B/C/D/E/F=2-351.
DR   PDB; 3E8E; X-ray; 2.00 A; A/B/E/I/L/P=2-351.
DR   PDB; 3KKV; X-ray; 1.80 A; A=2-351.
DR   PDB; 3ZO1; X-ray; 2.00 A; A=1-351.
DR   PDB; 3ZO2; X-ray; 1.98 A; A=1-351.
DR   PDB; 3ZO3; X-ray; 2.10 A; A=1-351.
DR   PDB; 3ZO4; X-ray; 1.65 A; A=1-351.
DR   PDB; 4AXA; X-ray; 1.90 A; A=1-351.
DR   PDB; 4C33; X-ray; 1.70 A; A=1-351.
DR   PDB; 4C34; X-ray; 1.78 A; A=1-351.
DR   PDB; 4C35; X-ray; 2.19 A; A=1-351.
DR   PDB; 4C36; X-ray; 1.98 A; A=1-351.
DR   PDB; 4C37; X-ray; 1.70 A; A=1-351.
DR   PDB; 4C38; X-ray; 1.58 A; A=1-351.
DR   PDB; 4IE9; X-ray; 1.92 A; A=1-351.
DR   PDB; 4IJ9; X-ray; 2.55 A; A=2-351.
DR   PDB; 4YXR; X-ray; 2.00 A; A=2-351.
DR   PDB; 4YXS; X-ray; 2.11 A; A=2-351.
DR   PDBsum; 1KMU; -.
DR   PDBsum; 1KMW; -.
DR   PDBsum; 1Q24; -.
DR   PDBsum; 1Q61; -.
DR   PDBsum; 1Q62; -.
DR   PDBsum; 1Q8T; -.
DR   PDBsum; 1Q8U; -.
DR   PDBsum; 1Q8W; -.
DR   PDBsum; 1SMH; -.
DR   PDBsum; 1STC; -.
DR   PDBsum; 1SVE; -.
DR   PDBsum; 1SVG; -.
DR   PDBsum; 1SVH; -.
DR   PDBsum; 1SZM; -.
DR   PDBsum; 1VEB; -.
DR   PDBsum; 1XH4; -.
DR   PDBsum; 1XH5; -.
DR   PDBsum; 1XH6; -.
DR   PDBsum; 1XH7; -.
DR   PDBsum; 1XH8; -.
DR   PDBsum; 1XH9; -.
DR   PDBsum; 1XHA; -.
DR   PDBsum; 1YDR; -.
DR   PDBsum; 1YDS; -.
DR   PDBsum; 1YDT; -.
DR   PDBsum; 2C1A; -.
DR   PDBsum; 2C1B; -.
DR   PDBsum; 2F7E; -.
DR   PDBsum; 2F7X; -.
DR   PDBsum; 2F7Z; -.
DR   PDBsum; 2GFC; -.
DR   PDBsum; 2GNF; -.
DR   PDBsum; 2GNG; -.
DR   PDBsum; 2GNH; -.
DR   PDBsum; 2GNI; -.
DR   PDBsum; 2GNJ; -.
DR   PDBsum; 2GNL; -.
DR   PDBsum; 2JDS; -.
DR   PDBsum; 2JDT; -.
DR   PDBsum; 2JDV; -.
DR   PDBsum; 2OH0; -.
DR   PDBsum; 2OJF; -.
DR   PDBsum; 2UVX; -.
DR   PDBsum; 2UVY; -.
DR   PDBsum; 2UVZ; -.
DR   PDBsum; 2UW0; -.
DR   PDBsum; 2UW3; -.
DR   PDBsum; 2UW4; -.
DR   PDBsum; 2UW5; -.
DR   PDBsum; 2UW6; -.
DR   PDBsum; 2UW7; -.
DR   PDBsum; 2UW8; -.
DR   PDBsum; 2UZT; -.
DR   PDBsum; 2UZU; -.
DR   PDBsum; 2UZV; -.
DR   PDBsum; 2UZW; -.
DR   PDBsum; 2VNW; -.
DR   PDBsum; 2VNY; -.
DR   PDBsum; 2VO0; -.
DR   PDBsum; 2VO3; -.
DR   PDBsum; 2VO6; -.
DR   PDBsum; 2VO7; -.
DR   PDBsum; 3AG9; -.
DR   PDBsum; 3BWJ; -.
DR   PDBsum; 3DND; -.
DR   PDBsum; 3DNE; -.
DR   PDBsum; 3E8C; -.
DR   PDBsum; 3E8E; -.
DR   PDBsum; 3KKV; -.
DR   PDBsum; 3ZO1; -.
DR   PDBsum; 3ZO2; -.
DR   PDBsum; 3ZO3; -.
DR   PDBsum; 3ZO4; -.
DR   PDBsum; 4AXA; -.
DR   PDBsum; 4C33; -.
DR   PDBsum; 4C34; -.
DR   PDBsum; 4C35; -.
DR   PDBsum; 4C36; -.
DR   PDBsum; 4C37; -.
DR   PDBsum; 4C38; -.
DR   PDBsum; 4IE9; -.
DR   PDBsum; 4IJ9; -.
DR   PDBsum; 4YXR; -.
DR   PDBsum; 4YXS; -.
DR   ProteinModelPortal; P00517; -.
DR   SMR; P00517; 8-351.
DR   BioGrid; 159584; 8.
DR   IntAct; P00517; 4.
DR   STRING; 9913.ENSBTAP00000008727; -.
DR   BindingDB; P00517; -.
DR   ChEMBL; CHEMBL2654; -.
DR   PaxDb; P00517; -.
DR   PRIDE; P00517; -.
DR   Ensembl; ENSBTAT00000008727; ENSBTAP00000008727; ENSBTAG00000006642.
DR   GeneID; 282322; -.
DR   KEGG; bta:282322; -.
DR   CTD; 5566; -.
DR   eggNOG; COG0515; -.
DR   GeneTree; ENSGT00790000122941; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P00517; -.
DR   KO; K04345; -.
DR   OMA; NAATANK; -.
DR   OrthoDB; EOG7VX8WD; -.
DR   TreeFam; TF313399; -.
DR   BRENDA; 2.7.11.11; 908.
DR   Reactome; REACT_273496; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; REACT_274117; PKA activation.
DR   Reactome; REACT_279372; PKA-mediated phosphorylation of CREB.
DR   Reactome; REACT_286999; Interleukin-3, 5 and GM-CSF signaling.
DR   Reactome; REACT_288981; PKA-mediated phosphorylation of key metabolic factors.
DR   Reactome; REACT_289962; Loss of Nlp from mitotic centrosomes.
DR   Reactome; REACT_301041; DARPP-32 events.
DR   Reactome; REACT_305537; Gluconeogenesis.
DR   Reactome; REACT_318110; PKA activation in glucagon signalling.
DR   Reactome; REACT_325957; Hedgehog 'off' state.
DR   Reactome; REACT_327729; Degradation of GLI2 by the proteasome.
DR   Reactome; REACT_333090; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; REACT_335146; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   Reactome; REACT_335730; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; REACT_335907; Factors involved in megakaryocyte development and platelet production.
DR   Reactome; REACT_337905; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; REACT_340866; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; REACT_341360; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; REACT_344993; Regulation of insulin secretion.
DR   Reactome; REACT_346955; Anchoring of the basal body to the plasma membrane.
DR   Reactome; REACT_348169; Rap1 signalling.
DR   Reactome; REACT_357749; CD209 (DC-SIGN) signaling.
DR   Reactome; REACT_358073; Degradation of GLI1 by the proteasome.
DR   EvolutionaryTrace; P00517; -.
DR   NextBio; 20806119; -.
DR   PMAP-CutDB; P00517; -.
DR   PRO; PR:P00517; -.
DR   Proteomes; UP000009136; Chromosome 7.
DR   GO; GO:0031588; C:AMP-activated protein kinase complex; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; IEA:Ensembl.
DR   GO; GO:0097546; C:ciliary base; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; ISS:AgBase.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0031594; C:neuromuscular junction; ISS:AgBase.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0097225; C:sperm midpiece; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004691; F:cAMP-dependent protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; ISS:AgBase.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:Ensembl.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0071374; P:cellular response to parathyroid hormone stimulus; IEA:Ensembl.
DR   GO; GO:0001707; P:mesoderm formation; ISS:AgBase.
DR   GO; GO:1901621; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl.
DR   GO; GO:0071158; P:positive regulation of cell cycle arrest; IEA:Ensembl.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:AgBase.
DR   GO; GO:2000810; P:regulation of bicellular tight junction assembly; IEA:Ensembl.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0061136; P:regulation of proteasomal protein catabolic process; IEA:Ensembl.
DR   GO; GO:0070613; P:regulation of protein processing; IEA:Ensembl.
DR   GO; GO:0050804; P:regulation of synaptic transmission; IEA:Ensembl.
DR   GO; GO:0048240; P:sperm capacitation; IEA:Ensembl.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR002290; Ser/Thr_dual-sp_kinase.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; cAMP; Cell membrane; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Kinase; Lipoprotein; Membrane;
KW   Mitochondrion; Myristate; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:6262777,
FT                                ECO:0000269|PubMed:6311252,
FT                                ECO:0000269|PubMed:9521123}.
FT   CHAIN         2    351       cAMP-dependent protein kinase catalytic
FT                                subunit alpha.
FT                                /FTId=PRO_0000086049.
FT   DOMAIN       44    298       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      299    351       AGC-kinase C-terminal.
FT   NP_BIND      50     58       ATP.
FT   NP_BIND     122    128       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     169    172       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    167    167       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027,
FT                                ECO:0000269|PubMed:6286662}.
FT   BINDING      73     73       ATP.
FT   MOD_RES       3      3       Deamidated asparagine; partial.
FT                                {ECO:0000269|PubMed:10684253,
FT                                ECO:0000269|PubMed:11152138,
FT                                ECO:0000269|PubMed:9521123}.
FT   MOD_RES      11     11       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES      49     49       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P17612}.
FT   MOD_RES     140    140       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P05132}.
FT   MOD_RES     196    196       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P17612}.
FT   MOD_RES     198    198       Phosphothreonine; by PDPK1.
FT                                {ECO:0000269|PubMed:6262777}.
FT   MOD_RES     202    202       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P17612}.
FT   MOD_RES     331    331       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P05132}.
FT   MOD_RES     339    339       Phosphoserine.
FT                                {ECO:0000269|PubMed:6262777}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:6262777}.
FT   MUTAGEN       3      3       N->D: No myristoylation.
FT                                {ECO:0000269|PubMed:9521123}.
FT   CONFLICT    202    202       T -> N (in Ref. 4; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    204    204       E -> Q (in Ref. 4; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    206    206       L -> S (in Ref. 4; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    287    287       N -> D (in Ref. 2; AA sequence and 3; AA
FT                                sequence). {ECO:0000305}.
FT   TURN         11     13       {ECO:0000244|PDB:2VO0}.
FT   HELIX        16     32       {ECO:0000244|PDB:4C38}.
FT   HELIX        41     43       {ECO:0000244|PDB:4C38}.
FT   STRAND       44     53       {ECO:0000244|PDB:4C38}.
FT   STRAND       56     63       {ECO:0000244|PDB:4C38}.
FT   TURN         64     66       {ECO:0000244|PDB:4C38}.
FT   STRAND       69     76       {ECO:0000244|PDB:4C38}.
FT   HELIX        77     82       {ECO:0000244|PDB:4C38}.
FT   HELIX        86     96       {ECO:0000244|PDB:4C38}.
FT   STRAND      107    112       {ECO:0000244|PDB:4C38}.
FT   STRAND      114    122       {ECO:0000244|PDB:4C38}.
FT   HELIX       129    136       {ECO:0000244|PDB:4C38}.
FT   HELIX       141    160       {ECO:0000244|PDB:4C38}.
FT   HELIX       170    172       {ECO:0000244|PDB:4C38}.
FT   STRAND      173    175       {ECO:0000244|PDB:4C38}.
FT   STRAND      181    183       {ECO:0000244|PDB:4C38}.
FT   HELIX       186    188       {ECO:0000244|PDB:2VO3}.
FT   STRAND      199    201       {ECO:0000244|PDB:3DND}.
FT   HELIX       203    205       {ECO:0000244|PDB:4C38}.
FT   HELIX       208    211       {ECO:0000244|PDB:4C38}.
FT   HELIX       219    234       {ECO:0000244|PDB:4C38}.
FT   HELIX       244    252       {ECO:0000244|PDB:4C38}.
FT   STRAND      260    262       {ECO:0000244|PDB:2UZV}.
FT   HELIX       264    273       {ECO:0000244|PDB:4C38}.
FT   TURN        278    280       {ECO:0000244|PDB:4C38}.
FT   TURN        282    284       {ECO:0000244|PDB:4C33}.
FT   TURN        286    289       {ECO:0000244|PDB:4C38}.
FT   HELIX       290    293       {ECO:0000244|PDB:4C38}.
FT   HELIX       296    298       {ECO:0000244|PDB:4C38}.
FT   HELIX       303    307       {ECO:0000244|PDB:4C38}.
FT   STRAND      322    325       {ECO:0000244|PDB:4C34}.
FT   STRAND      326    328       {ECO:0000244|PDB:1STC}.
FT   TURN        345    350       {ECO:0000244|PDB:4C38}.
SQ   SEQUENCE   351 AA;  40620 MW;  59DDD227D2DEEE5D CRC64;
     MGNAAAAKKG SEQESVKEFL AKAKEDFLKK WENPAQNTAH LDQFERIKTL GTGSFGRVML
     VKHMETGNHY AMKILDKQKV VKLKQIEHTL NEKRILQAVN FPFLVKLEFS FKDNSNLYMV
     MEYVPGGEMF SHLRRIGRFS EPHARFYAAQ IVLTFEYLHS LDLIYRDLKP ENLLIDQQGY
     IQVTDFGFAK RVKGRTWTLC GTPEYLAPEI ILSKGYNKAV DWWALGVLIY EMAAGYPPFF
     ADQPIQIYEK IVSGKVRFPS HFSSDLKDLL RNLLQVDLTK RFGNLKNGVN DIKNHKWFAT
     TDWIAIYQRK VEAPFIPKFK GPGDTSNFDD YEEEEIRVSI NEKCGKEFSE F
//
